Dermal matrices are already being used in shoulder repair. Pictures of one technique can be found here.
The authors of this paper state that the risks associated with this procedure include those that come with using normal dermal matrix materials - the risk of infectious disease transmission, failure of graft incorporation, and foreign-body reaction to the graft tissue.
BTM is synthetic and so has no cross-species disease transfer risk and provides no food supply for bacteria. The BTM chambers compartmentalize the wound and create a physical barrier that aids in minimizing foreign body response. And to date, BTM has demonstrated very low levels of graft failure.
I can see absolutely no reason why BTM couldn’t be adapted for use in shoulder surgery.
Ann: Director Share Purchase - David Williams, page-75
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |